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1. Introduction
End Stage Renal Disease (ESRD) is an important public health concern around the globe.
It is associated with high morbidity and mortality being Hemodialysis (HD) the main ap‐
plied therapy. [1]
A  recent  study  (HEMO  study)  could  not  show  any  decrease  in  the  morbidity  and/or
mortality associated with increases in the dose -expressed as equilibrated Kt/V (eqKt/V)-
and/or the flow (comparing high versus low flux,  where high flux is  defined as a Kt/V
of  Beta  2  microglobulin  (B2M)  ≥  20  ml/min)  when  utilizing  the  three-times-a-week  (3-
times/wk HD) schedule therapy. [2]
This led to development of several HD schedules proposals based on the variation of the
session time duration (TD) as well  as on its  weekly frequency (Fr).  However,  more fre‐
quent HD schedules require new indexes to measure the delivered dose. In this context,
the Equivalent Renal Clearence (EKR) [Casino y López] [3] and Standard Kt/V (stdKt/V)
[Gotch]  [4]  indexes  have  been  proposed  to  quantify  the  dialysis  dose  for  different  HD
frequency schedules.
The EKR concept equalizes the time-averaged concentration (TAC) of Urea (U) for differ‐
ent  therapies  which is  then normalized by U distribution Volume.  Gotch has  proposed
that  the weekly dialysis  dose (WDD) is  better  expressed as standardized kt-V (stdKt/V)
when dialysis is more frequent than 3-times/wk. Standard Kt/V combines treatment dose
and frequency allowing comparison of  intermittent  (HD, High flux HD, Hemofiltration,
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etc)  and continuous (Continuous Ambulatory Peritoneal  Dialysis)  therapies;  the formula
is expressed as U generation rate (G) rate divided by the average peak concentration. [4]
EqKt/V is the true dialysis dose per session occurring when U rebound (R), which is related
to compartments and flow disequilibrium produced during HD treatment, is completed
30-60 minutes after the end of the HD session.
The determination of eqKt/V requires the measurement or the “prediction” of the true Eq U
because the value of sp (single pool)Kt/V - a dimensionless ratio which includes Clearence
of dialyzer (K), duration of treatment (TD) and volume of total water of the patient (V) - is
greater than the Kt/V achieved in the patient which is calculated using the immediate
postHD blood U concentration.
In the last decade, several formulas were developed to predict eq Kt/V trying to avoid the
extraction of an additional blood sample. The Daugirdas and Schneditz “rate formula” is the
most popular and validated equation and it is based in the prediction of eqKt/V as a linear
function of spKt/V and the rate of dialysis (K/V). [5]
An alternative and robust formula, based in the double pool analysis by Smye, [6] is the
equation of Tattersall where he described a soluble time constant: the patient equilibration
time (tp). [7]
The majority of these formulas of prediction have been validated in the 3-times/wk HD
schedules.
New  formulas  to  predict  eq  Kt/V  have  been  recently  published.  Examples  include  the
eqKt/V  formula  based  on  observations  of  the  HEMO  [8]  study  and  two  others  devel‐
oped  by  Leypoldt  (based  on  blood  sample  analysis  during  hemofiltration  and  short
and daily HD) [9].
The high accuracy of the extracellular U concentration evolution during and after (UR) an
HD session by double pool U kinetic model has been verified in several studies. [10]
Access and cardio-pulmonary recirculation can both influence the UR, but the effect occurs
in the first minutes after the end of HD and is considered to be mild. [10]
Several factors other than clearance of U might play a role in morbidity and mortality of he‐
modialyzed patients.
One of them, recently revised, is the role of the “denominator” to normalize the Kt. The
results derived from the HEMO study showed that Kt/V failed to explain the paradoxi‐
cal outcomes related to size (underweight versus obese patients) and gender. This factor
was considered in the Frequent  Hemodialysis  Network (FHN) study which is  currently
underway. The investigators included the body surface area (BSA) as a potential tool for
a better normalization of Kt and to allow more appropriate comparison among different
HD populations. [11]
Since 1980 the idea of emulating reality in a computer environment by simulation rapid‐
ly  spread  among  biomedical  researchers,  being  accepted  as  one  of  the  most  powerful
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tools both for understanding phenomenological aspects of a chosen physics or physiolog‐
ical  complex  and for  predicting  functional  or  operative  conditions  of  technological  sys‐
tems.  The  main  concept  of  this  approach  relies  in  numerically  solving  a  mathematical
model that governs a chosen physical system, whose the analytical solution is not known
or potentially dangerous to reach for a specific application. In spite of many efforts spent
in  the  past  for  formulating  accurate  and  robust  algorithms  for  solving  mathematical
models,  the  effectiveness  of  that  approach  heavily  dependent  on  computational  resour‐
ces.  This  led  to  only  recent  widespread  use  of  simulation  strategy  both  scientific  and
medical problems [12].
A variable volume double-compartment (VVDC) kinetic model can reflect the behavior of
different molecules and can be used as a mirror to analyze the profile in vivo by taking
blood samples during the HD procedure. [13]
In this scenario, the computational simulation including all the variables which affect the di‐
alysis procedure can be a safe and useful tool to mimic many treatment schemes to help im‐
prove our knowledge of the dialysis therapy. [14]
The aim of this study is to utilize a variable volume double-compartment (VVDC) kinetic
model to simulate:
1. Several clinical situations that allow comparison between the true eqKt/V and all the
developed predictors, including the effect of increasing the TD and Fr.
2. Changes in Kt/V, EKR and stdKt/V related to changes in TD and Fr.
3. Comparison between using V with BSA to normalize K.
2. Materials and methods
2.1. Simulation and analysis
A variable volume double-compartment (VVDC) kinetic model has been implemented
based on the existing models of the U concentration behaviour. The model is described in
Figure 1 and the equations are as follows:
( ) ( ) ( ( ) ( )) ( )( ( ) )e e c e i e e r dd V C t G K C t C t C t K t K Kdt = - - - + + (1)
( ) ( ) ( ( ) ( ))i i c e id V C t K C t C tdt = - (2)
( ) ( )dV t tdt a= (3)
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Figure 1. Scheme of Variable-Volume Double Compartment dialysis kinetic model
Whereas “V” is: solute distribution volume, “C”: solute concentration, “K”: clearance con‐
stant, “G”: solute generation, “c”: cellular, “e”: extracellular, “i”: intracellular, “r”: renal,
“d”: dialyser, a: volume change velocity (this constant is positive between dialysis sessions
and negative during them), “t”: time. Equations 1, 2 and 3 make a dependent differential
equation system that can be numerically solved. Through these simulations, it is possible to
obtain the time profile of intra and extracellular volumes and concentrations of the studied
solutes (figure 2).
By defining a behaviour determined for several time intervals on certain variables, such as α
and Kd, it is possible to simulate different dialysis schedules, regarding session duration
times (TD) and time between dialysis sessions or dialysis frequency (Fr).
Hemodialysis362
 (a) 
(b) 
) 
(c) 
Figure 2. (a) Simulation of a profile during HD and the rebound of the solute immediately after the end. (b) Simula‐
tion of the weekly HD profile showing the effect of increasing the TD with fixed Kd and Kc. (c) Urea dinamycs simulat‐
ed with double or single pool.
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2.2. Simulated systems
2.2.1. Comparison between the true eq Kt/V and all the developed predictors
The simulations assumed that the subjects had a solute distribution volume of 580 ml/Kg
and the intra and extracellular distribution relation is 2/3 and 1/3 of the total V. The extra-
renal clearance constant (Ker) was considered invalid for the U.
Residual renal clearance (Kr) was 0. 1ml/min in all the cases.
Dialysis schedules with a duration between 2 and 8 hours at 2-hour-intervals of 2 hour were
simulated and the weekly frequency of treatment were 3 and 7 days/wk.
The simulations resulted in a time-dependent evolution of the molecule concentration under
study (U) in each of the compartments, that is, the intracellular (Ci) and extracellular (Ce)
compartments.
We analysed 1005 determinations of U pre HD, U posHD and eqU (60 minutes after the end
of the simulated session). This determinations were obtained in the midweek of the 4th and
10th week of simulation
These determinations were product of the manipulation of six (6) variables-Table 1-
Weight Kc(ml/min) Kd(ml/min) Uonset(mg%) UF(ml/session) UR%
60-120 400-1000 100-250 160 -240 500-4000 3.65-17.8
Table 1. Range of values of the different simulated variables.
U G was 6. 25mg/min in all the simulations.
2.2.2. Formulas
Simulated eqKt/V was compared with the previously described predictors with the next
formulas :
/ pos
pre
UKt V Ln U
æ öç ÷= ç ÷è ø
(4)
/ eq
pre
UKt V Ln U
æ öç ÷= ç ÷è ø
(5)
/ / * 35TATTERSALL
tKt V Kt V t
é ù= ê ú+ë û (6)
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// / 0.6 * 0.03DAUGIRDAS Kt VKt V Kt V t= - + (7)
// / 0.39 *HEMO Kt VKt V Kt V t= - (8)
1
// 0.924 * / 0.395 * 0.056LEYPOLDT Kt VKt V Kt V t= - + (9)
2 // 0.915 * / 0.485 * 0.106LEYPOLDT Kt VKt V Kt V t= - + (10)
2.3. Changes in Kt/V, EKR and stdKt/V related to changes in TD and Fr
Typical 80-kg-patient with a residual renal clearance (Kr) of 0. 1ml/min and a weight gain a
(interdialysis) and ultrafiltration (intradialysis) of 0. 65 ml/min was chosen to simulate the
different therapeutic dialysis schedules.
The assumption was that this typical patient would have a solute distribution volume of 580
ml/Kg (46. 4 litres) and when the solute is U, the intra and extracellular distribution relation
is 2/3 and 1/3 of the total V. The extrarenal clearance constant (Ker) was considered invalid
for the U.
Dialysis schedules with a duration between 1 and 8 hours at intervals of 1 hour were simu‐
lated and the weekly frequency of treatment was changed from 3 to 7 days a week on each
of them thus obtaining 28 different schemes.
The Fr applied to the simulations does not represent sessions uniformly distributed through
the week; it was implemented according to the time tables used in the usual HD practice.
For the 3-times/wk Fr, three sessions with an interval between the beginning of sessions of
48, 48 and 72 hours (that is, Monday, Wednesday and Friday) were performed. For the 4-
times/wk sessions, the intervals are 24, 48, 24 and 72 hours. For the 5-and 6 -times/wk ses‐
sions, 4 and 5 intervals of 24 hours and the last one of 72 and 48 hours, respectively, are
established. When the Fr is of 7-times/wk, the distribution is uniform.
The simulations resulted in a time-dependent evolution of the molecule concentration under
study (Urea) in the intracellular (Ci) and extracellular (Ce) compartments.
Over the U time profiles, the real Time Average Concentration (TAC) is calculated. Since the
main objective was to evaluate which of the proposed indexes more accurately showed the
dose changes caused by the scheme changes, the behaviour of the weekly Kt/V, EKR (Casi‐
no), std Kt/V (Gotch) and the rebound percentage (% rebound), were compared according
the following formulas:
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2.4. Hemodialysis simulation tool: HD-SIM
The simulations of hemodyalisis kinetics were performed through the utilization of a soft‐
ware specially developed for hemodyalisis simulation: HD-SIM. [15] This software was de‐
veloped on MATLAB (c) platform and consists of a calculation core and a graphical user
interface (GUI).
HD-SIM  calculation  core  utilizes  MATLAB  ®  (version  6.  5)  simulation  package  SIMU‐
LINK®  to  support  the  VVDC  kinetics  model.  Given  the  set  of  required  parameters
through the GUI, solute compartmental concentrations (Ce and Ci) and volumes (Ve and
Vi) are calculated as functions of time. Concentration-time profiles are used for the calcu‐
lation of different hemodyalisis quantity-quality estimators such as: TAC, EKR, Kt/V, and
stdKt/V.  The  calculation  core  solver  is  used  with:  ode113  algorithm (Adams –  variable
step)  that  is  recommended  by  MathWorks  for  narrow  tolerances,  automatic  integration
step,  maximum step of  1  (1  hr),  duration of  1680 (10 weeks),  absolute tolerance of  10⁻⁷
(10⁻⁷ mg/ml) and relative tolerance of 10⁻⁷.
HD-SIM GUI provides a friendly set of windows that allows inserting patient and dialyzer
specific data into the simulation system that is required to feed the VVDC model, defining
sets of TDs and Frs to evaluate a wide range of treatment schedules, and managing the out‐
come of the simulations from visualizing estimator values and concentration profiles to file-
saving selected results. (figures 3, 4 and 5)
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Figure 3. Patient and simulation data displayed by HD-SIM
Figure 4. Patient and simulation data displayed by HD-SIM
Analysis of the Dialysis Dose in Different Clinical Situations: A Simulation-Based Approach
http://dx.doi.org/10. 5772/53529
367
Figure 5. HDSIM running the simulations.
Table 2 shows the values at the the beginning of the simulation.
Solute Ce onset (mg %) G (mg/min) Kc(ml/min) Kd(ml/min)
Urea 230 6.25 600 250
Table 2. Values at the beginning of the simulation
3. Statistical analysis
All values are expressed as mean±standard deviation (sd) or median (range) as appropriate.
Correlation coefficients were determined using the Pearson method. For analysis of agree‐
ment between methods (for example simulated (sim) eqKtV versus EqKtV predictors) we
used Bland Altman analysis. To compare sim eqKtV with predictors we also used analysis
of error: mean error (sim eqKtV-predictor) and % mean error ( (sim eqKtV-predictor)/ sim
eqKtV) x 100). We used MedCalc version 12. 3. 0(MedCalc Software,Mariakerke,Belgium)
for the statistical analysis.
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4. Results
4.1. Prediction of the eqKt/V
The eq KtV delivered in 1005 simulations was 0. 84±0. 47 with a median of 0. 78 and a range
between 0. 10 and 2. 54, which represent the wide range of values commonly seen in current
clinical practice. (Table 3)
eqKt/V Tattersall Daugirdas HEMO Leypoldt 1 Leypoldt 2
Minimum 0.10 0.13 0.14 0.13 0.18 0.13
1st Quart 0.47 0.50 0.50 0.51 0.52 0.46
Mean 0.85 0.87 0.88 0.89 0.87 0.80
Median 0.78 0.80 0.82 0.82 0.81 0.75
Table 3. Statistical summary of Simulated and predicted eqKt/V values by different formulas. (1st Quart=first quartile)
4.2. Behaviour of predictors
All predictors showed a high Pearson correlation coefficient (≥ 0. 99) with sim eqKt/V and
among themselves.
Daurgidas, Tattersall, HEMO and Leypoldt1 underestimated sim eqKt/V. Leypoldt2 was the
only one to overestimate the sim eqKtV. (Tables 4 and 5)
Daugirdas Tattersall HEMO Leypoldt1 Leypoldt2
Mean -0.0302 -0.0199 -0.0435 -0.0244 0.0428
SD 0.03680 0.03255 0.02959 0.05039 0.05670
Median -0.0350 -0.0241 -0.0459 -0.0300 0.0304
Minimum -0.101 -0.0836 -0.110 -0.110 -0.0454
Maximum 0.0783 0.0827 0.0721 0.170 0.259
Table 4. Mean Error (ME) between sim eqKt/V and predictors
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Daugirdas Tattersall HEMO Leypoldt1 Leypoldt2
Mean 5.63 4.32 7.47 7.63 -3.18
SD 7.7 6.9 7.42 11.83 6.67
Median 4.65 3.23 5.89 4.60 -3.9
Minimum -2.14 -2.26 -1.95 -1.14 -2.82
Maximum 5.37 3.54 4.08 8.55 3.43
Table 5. % Error (% ME) between sim eqKt/V and predictors
The lower error of prediction expressed as ME or % ME was obtained with the Tattersall
and the Daurgidas formula. Leypoldt1 and 2 showed the worst predictive performance.
One interesting point was the effect of increase TD of Fr it was used in unconventional
schedules (different from 3-times/wk). Error was higher in schemes shorter than 4 hours and
the increasing of Fr did not affect the prediction (Figures 6 and 7)
Figure 6. Effect of the TD and increased Fr in the % error prediction of eqKt/V
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Figure 7. Effect of the TD and increased Fr in the % error prediction of eqKt/V
4.3. Bland-Altman analysis
A Bland-Altman analysis of agreement between gold standard (sim KtV) and eqKt/V predic‐
tors was performed. Tattersall and Daugirdas formulas showed the lower mean difference
(±2sd): -0. 02 (+0. 04 -0. 08) and -0. 03 (+0. 04 -0. 1) respectively with a Gaussian distribution
of error. Both Leypoldt formulas showed higher error with the increasing of the magnitude
of eqKtV. HEMO study formula showed a higher mean difference than Tattersall and Dau‐
girdas formulas with a lower 95% agreement interval (+0. 01-0. 1) (figure 8)
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 Figure 8. Left side: Bland Altman plot comparing simulated eq Kt/V and predicted eq Kt/V by different predictors formu‐
laes. Right side: Histogram of Error between simulated eq Kt/V and predicted eq Kt/V by different predictors formulas.
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4.4. Quantification of the Weekly Dialysis Dose (WDD)
The minimal dialysis dose recommended by the DOQI standards (Kt/V U/session = 1. 2) cor‐
responded to EKR U =3. 17 ml/min and stdKt/V U = 2. 07 ml/min in a usual scheme of 3
days/4 hours (3d4hs) and the high dose equivalent similar to HEMO study (EqKt/V=1. 4)
was 4. 28 ml/min and 2. 57 ml/min for stdKt/V in a schedule of 3 days 6 hours. Figure 9
shows the stdKt/V behaviour related to increase of TD and Fr as well as the equivalent val‐
ues of minimal and high Kt/V.
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Figure 9. stdKt/V behaviour related to increase of TD and Fr as well as the equivalent values of minimal and high Kt/V.
Table 6 shows tipical values of EKR, stdKt/V, wk Kt/V (weekly Kt/V) and Kt/V by session
according changes in TD y Fr in a typical 80-kg-patient.
Frequency time[h] EKR (ml/min) stdKt/V(ml/min) wk Kt/V(ml/min) KTV/Session
3 4 3.17 2.07 3.55 1.18
3 8 5.11 2.92 5.82 1.94
4 4 4.23 2.78 4.61 1.15
7 2 4.06 3.05 4.78 0.68
7 4 7.45 5 7.52 1.07
7 8 12.69 7.75 10.54 1.51
Table 6. EKR, stdKt/V, wkKt/V and Kt/V by session according changes in TD and Fr in a typical 80-kg-patient. (Ce
onset=230;KD=250 ml/min;Kc=600ml/min.
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The weekly Kt/V, EKR and std Kt/V showed a high correlation to express increasing of TD
and Fr (weekly Kt/v-std Kt/V r= 0. 987 EKR-stdKt/V r=0. 9937) showing the weekly Kt/V (5.
68±2. 46) and the EKR (5. 55±3. 02) values to be higher than std Kt/V (3. 56±1. 76)
The behaviour proved different when the three indexes were separately analysed. When they
are compared to quantify 3-times/wk and weekly schedules, the ekr and std Kt/V have a simi‐
lar behaviour, the EKR tending to overestimate the WDD as the TD increases. (Figure 11) When
the difference EKR-std Kt/V is showed in a graph (Figure 10) a high correlation of it (R2=0. 99) is
verified, with a logarithmic increase of the Kt/V/session and is lower with the increase of Fr in a
fixed TD. The weekly Kt/V has a behaviour similar to that of the EKR in the 3-times/wk sched‐
ules but clearly fails in the daily schedules, especially in the TD schedules >4 hours.
When the Kt/V-session is analysed, the results match. The Kt/V/session increases as the TD
increases when a certain number of sessions are fixed (Fr). When it is analysed for different
Frs, the Kt/V/session only shows differences when duration is > 4 hours; however, if the Fr
varies and the TD is fixed, instead we can observe that the Kt/V/session is not able to re‐
spond to the dose increases and tends to decrease as the WDD increases due to an increment
of the Fr. (Figure 11)
The U rebound is complete one hour after the end of the HD session in all the simulations,
decreasing as the TD increases.
Figure 11 showed the effect of TD and Fr on different predictors of the WDD (wkKt/V, EKR
and stdKt/V) as well the changes Kt/V-session.
Figure 10. Difference (%) EKR-stdKtV related to Kt/V by session
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 Figure 11. Effect of changes in increasing of TD and Fr on the behavior of WDD predictors (wkKt/V, stdKt/V, EKR) and
Kt/V by session. (WDD=Weekly Dialysis Dose (ml/min)
4.5. Comparison of V with BSA to normalize Kt/V
In the last four decades dialysis dose expressed as KtV has been widely used due to its low
complexity and ability to predict to be a strong predictor or mortality in HD population.
However, recent studies showed paradoxical outcomes related to sex and higher mortality
in patients with high Kt/V and low Volume, leading to the proposal of a normalized volume
using and the correction by a Volumen normalized by Body Surface Area (BSA). has been
proposed. [16]
We randomly simulated 1031 K*t with a range of between 14400 ml/min and 57600 ml/min
and then Kt/V (using Watson formula for Volume) and Kt/V corrected by BSA (Dubois for‐
mula) were calculated and analysed
KtV values delivered by simulation showed a mean of 1. 01, a median of 0. 99, a range be‐
tween 0. 29-2. 44 and a standard deviation of 0. 40 The results of the allometrical correction
of Volume Watson formula by BSA were 0. 084*V 0. 86 (female) r=0. 98 and 0. 1229*V 0. 73
(male) r=0. 99. (Figure 12)
The results after V normalized by BSA clearly changed between men and women and the
overestimation in patients with lower volumes was corrected (Table 7 and figures 13 and 14)
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Sex
f m
Mean SD Mean SD
Kt/V 1.158 0.4354 0.921 0.3415
Kt/Vcorr 1.862 0.6891 2.489 0.8909
Table 7. Kt/V and Kt/V corrected by BSA (Dubois) according to sex.
Figure 12. Allometric regression between Body Surface Area (Dubois) and Volume (Watson)
 
Figure 13. Effect of changes in Volume and Sex on BSA-normalized Kt/V and Watson Kt/V
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5. Discussion
In this work we propose the simulation with a VVDC kinetic model as a useful and safe
tool to investigate, learn and find out the numerous aspects of the HD treatment related
to dialysis dose. Single pool models used by Gotch [10] to developed the pharmaco- ki‐
netic  concept  of  Kt/V  are  simpler  and  also  useful  but  it  frequently  leads  to  errors  in
showing  the  true  behaviour  of  little  known  molecules  or  not  yet  validated  treatments.
VVDC kinetic  model  is  used in  current  studies  that  analyze  the  influence  of  increasing
TD and Fr  in  HD outcomes after  the  failure  of  HEMO study to  demonstrate  better  re‐
sults with high dose expressed as eqKtV. [2]
Exponencial decay curves defined by WWDC to fit dialysis dose by session are actually
used in several medical devices based on ionic dialysance or urea sensors. [17] [18]
We used WWDC based curve fitting and neural networks to predict dialysis dose from sam‐
ples provided by an on-line urea monitor. [17]
The main interpretation of the double compartment [19] represent intra and extracellular
fluid spaces, with diffusion of molecules between the spaces characterised by a mass trans‐
fer coefficient, Kc. This interpretation is based on the observation that Kc correlated with pa‐
tient size. This model had been deeply developed by Smye and it had been the basis of the
Tattersall formula. However, Scheneditz et al suggests that the two compartment based in
different regional tissue flows (high and low blood flow) may describe urea distribution,
and transport during dialysis, more accurately. This theorical approach also permited the
development of a formula for dialysis dose that accounts for molecular rebound but only is
based only on measurements of urea made during HD procedure. This formula has proved
higher clinical usefulness: the Daurgirdas formula.
In this study we confirmed the robustness of the two widespread eqKtV predictors devel‐
oped under the two different ways: Tattersall [7] and Daugirdas formulas. They showed a
high accuracy in the numerous simulated schedules. The lower error of Tattersall formula
has been validated in clinical situations and could be explained in our study because it was
developed under a theorical approach using a diffusion –based VVDC.
Formula emerged from the blood U samples analysis of 1131 patients in the HEMO study
[8] showed as an interesting approach. It behaved with a higher error than Tattersall and
Daurgirdas formulas but showing a very low bias in all the simulations.
Eq KtV was confirmed as the metric of dialysis session in the thrice a week schedule. Equiv‐
alent dose of stdKt/V for eqKt/V in schedules>3-times/wk may be easily calculated in a
graphical fashion (Figure 9)
The main issue which justifies the fact that Kt/V U is considered the key of the adequacy of
dialysis is that it is related to mortality. However, many studies have questioned the utility
of Kt/V: mainly, scaling for the volume is a confounding factor since gender and body mass
index directly affect morbidity and mortality in HD patients. [20]
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In our study the influence of the denominator to achieve a real dose independent of sex and
volume showed similar results with others studies.
VVDC proved particularly useful when we analysed the new proposed predictors of the
WDD: EKR and standard Kt/V.
Std KtV was confirmed as  the  best  project  to  explain  the  different  schedules.  EKR was
showed  closely  related  with  Kt/V  and  sensitive  to  changes  in  TD,  overestimating  the
dose in daily HD schedules.  VVDC allowed to graph different weight,  dialyzer and pa‐
tient clearences, etc.
Other molecules such as B2M [21] and phosphorus related to mortality and different behav‐
iour with urea have not been simulated in this work but VVDC have been successfully used
for both. B2M is a molecule of high molecular weight, with typical lower levels in plasma
and lower distribution Volume fully explained by VVDC when we know completely their
characteristics. On the contrary, Phosphorus [22] shows a heterogeneous and complex be‐
haviour that cannot be completely validated with a VVDC kinetic model.
In addition to U kinetics, clinicians must consider clinical indicators (in example extracellu‐
lar volume control, blood pressure, anemia and cardiovascular status) and comorbidities
(diabetes, ageing, undernutrition) when using frequent or prolonged dialysis no forgetting
to provide the best possible clinical results and quality of life.
6. Conclusions
In our experience, a VVDC kinetic model proved to be showed as a useful and safe tool to
analyse different HD schedules and novels techniques before the clinical validation. The use
of graphical interfaces to extrapolate the numerical results enhanced the VVDC simulation.
Clinical practice and simulation interact in a permanent feedback. Std KtV was confirmed as
the best project to explain the different schedules. Tattersall and Daugirdas showed highly
accurate in the numerous simulated schedules.
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